Nicole Amoruso’s senior field hockey season at Lakeland High included a rare cancer diagnosis, thyroid surgery and a return to competition. The 17-year-old captain finished as the team’s leading scorer, with eight goals, and earned second-team All-Passaic County honors, NJ.com reported.
Amoruso was diagnosed with papillary thyroid cancer at Children’s Hospital of Philadelphia on Aug. 12, 2026, after a neck nodule was found during a search for answers to ongoing health problems, according to NJ.com. She had surgery on Aug. 31 to remove half of her thyroid. The outlet reported that she missed two games and returned to the field about two weeks after the operation.
A return that depended on individual medical clearance
Her return was specific to her medical circumstances, not a general timetable for athletes after cancer treatment. The NJSIAA’s preparticipation physical evaluation form says a physician may rescind an athlete’s medical eligibility if a condition arises after clearance. It does not set a post-surgery return schedule or explain Amoruso’s individual clearance; NJ.com reported that her doctors cleared her to play.
Research on activity among young cancer survivors offers a separate, limited perspective—not a measure of an individual athlete’s readiness. The National Cancer Institute reported that, in one pilot study, moderate-to-vigorous physical activity rose by an average of nearly five minutes a week in the intervention group and fell by more than 24 minutes a week in the control group. Those study results do not establish a return-to-sport timeline or predict Amoruso’s recovery.
The cancer type is rare at her age: CHOP medical director Andrew Bauer told NJ.com it occurs in about five in one million people Amoruso’s age. CHOP says papillary cancer accounts for about 85% to 90% of differentiated thyroid cancers and that pediatric patients with differentiated thyroid cancer have a survival rate above 95% 20 to 30 years after treatment. Those are broad population figures, not a prognosis for Amoruso.
Follow-up remains ahead
Amoruso has additional blood work and an ultrasound scheduled through March 2027 and hopes then to be declared in remission, NJ.com reported. The results will help determine whether further treatment is needed, so her outcome remains unresolved. For now, the reported season’s eight goals and county honor mark what she achieved after returning—not a substitute for the medical follow-up still to come.
